
#128 – IDWeek 2025 Recap
Breakpoints
00:00
PIVOT-PO: Oral Tebipenem for Complicated UTIs
Ryan summarizes the PIVOT-PO trial showing oral tebipenem noninferior to IV imipenem for complicated UTIs, including ESBL cases.
Play episode from 01:37
Transcript


